In: Biological Chemistry, 2015, vol. 396, no. 6-7, p. 795-802
|
In: Cell Biochemistry and Biophysics, 1999, vol. 30, no. 3, p. 437-454
|
In: International Immunology, 1995, vol. 7, no. 10, p. 1607-1615
|
In: Annals of Oncology, 2014, vol. 25, no. 3, p. 747-753
|
In: Toxicological Sciences, 2011, vol. 119, no. 2, p. 257-269
|
In: Histopathology, 2011, vol. 59, no. 5, p. 965–974
Aims: Medullary breast cancer (MBC) is a biologically distinct subtype of breast cancer characterized by prominent lymphocytic infiltrates and a favourable clinical outcome. Tumour-infiltrating CD8+ effector T cells may contribute to the good prognosis of this type of cancer; however, certain subtypes of lymphocyte, such as FoxP3+ regulatory T cells (Tregs), can also suppress antitumour...
|